Prevtec Microbia announced that it recently submitted a dossier to the European regulatory authorities, for the central approval of its swine E. coli vaccine Coliprotec F4.
This vaccine has been developed by Prevtec Microbia and will be exclusively distributed by Elanco Animal Health (Elanco) in Europe, a major player in animal health with operations in more than 75 countries.
This is an extension of the collaboration of Prevtec and Elanco, which is already marketing Coliprotec in Canada.
To comment, login here
Or register to be able to comment.